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Özet
Abstract
Objective: The purpose of study was to investigate erythrocyte indices in patients 
with preeclampsia. 
Materials and Methods: The study population consisted of 102 patients with 
preeclampsia (49 mild, 53 severe preeclampsia) and 98 control pregnant patients. 
For the entire study population, red blood cell indices, including baseline mean 
corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular 
hemoglobin concentration (MCHC), red cell distribution width (RDW), and red 
blood cell (RBC) were measured by using an automatic blood counter.
Results: In the preeclampsia group, the median RDW was 15% (13.8-16.57), 
whereas in the control group it was 13.9% (13-15.6) (p<0.01). On the other hand, 
the mean MCV value was 80.42±7.86 (fL) in preeclampsia group and 83.88±2.31 (fL) 
in control group (p=0.003). Besides, the mean MCHC value was 33.66±1.71 (g/dL) 
in preeclampsia group and 33.09±1.48 (g/dL) in control group (p=0.012). However 
MCH and RBC values were not statistically different between the groups. (p>0.05) 
Moreover, subgroup analysis revealed that RDW levels were significantly increased 
in preeclampsia subjects than in mild preeclampsia patients (15.4% (13.9-17.45) vs 
14.3% (13.7-15.7), p=0.031), MCV levels were decreased (78.81±7.91 (fL) vs 82.16± 
7.43 (fL), p=0.03), RBC values were increased (4.16 (3.79-4.85)x(1012/L) vs 3.82 (3.45-
4.34)x(1012/L), (p=0.006)) in patients with severe preeclampsia when compared to 
the patients with mild preeclampsia. In the receiver operator characteristic (ROC) 
analysis of subjects with and without preeclampsia, RDW and MCV showed high 
predictive values (p<0.01). Besides, in ROC analysis of preeclampsia patients with 
different severities, RDW and RBC showed the ideal predictive values (p=0.006, 
p=0.031, respectively).
Conclusion: Our study results revealed that among the red blood cell indices, only 
increased RDW values were associated with both the presence and the severity of 
preeclampsia.
Amaç: Bu çalışmanın amacı preeklampsi tanısı konmuş hastalarda eritrosit 
indekslerini araştırmaktır. 
Gereç ve Yöntemler: Bu çalışmaya 102 preeklampsi (49 hafif ve 53 şiddetli 
preeklampsi olmak üzere) ve 98 kontrol hastası dahil edilmiştir. Tüm çalışma 
grubunda eritrosit indeksleri olan ortalama korpuskular hacim (MCV), ortalama 
korpuskular hemoglobin (MCH), ortalama korpuskular hemoglobin konsantrasyonu 
(MCHC), eritrosit sayımı ve eritrosit dağılım genişliği değerleri otomatik kan sayım 
cihazı ile ölçüldü. 
Ad dress for Cor res pon den ce/Ya zış ma Ad re si:
Sümeyra Nergiz Avcıoğlu MD,
Adnan Menderes University Faculty of 
Medicine, Department of Obstetrics and 
Gynecology, Aydın, Turkey
Phone : +90 256 211 28 71
E-mail : sumeyranergiz80@gmail.com
Key words
Preeclampsia, red blood cell indices, RDW
Anah tar ke li me ler
Preeklampsi, eritrosit indeksleri, RDW
Received/Geliş Ta rihi : 08.06.2015 
Accepted/Ka bul Ta ri hi : 11.06.2015
doi:10.4274/meandros.2241
© Meandros Medical and Dental Journal, published by 
Galenos Publishing. 
© Meandros Medical and Dental Journal, Galenos 
Yayınevi tarafından basılmıştır. 
Meandros Medical and Dental Journal 2015;16:35-42 35
36 Avcıoğlu et al. Preeclampsia and Erythrocyte Indices
Introduction
Hypertensive disorders complicating pregnancy 
are responsible for a high incidence of maternal 
deaths (1). Preeclampsia is a disorder of pregnancy 
characterized by hypertension with a blood pressure 
of ≥140/90 mmHg and proteinuria with ≥300 mg/24 
h urine or ≥2+ dipstick after 20th week of gestation 
(2). It is seen in 3-7% of pregnancies. It is one of the 
major causes of mortality during pregnancy with 
hemorrhage and thromboembolism (3). It has been 
determined that 18% of maternal deaths occur due 
to preeclampsia (4). If the disease begins before 34 
weeks of gestation, it is early and if it starts after 34 
weeks, it is late preeclampsia (5). 
In the literature, there have been many theories 
about preeclampsia. First, defective trophoblast 
invasion was claimed to cause preeclampsia (6). 
Another theory about preeclampsia was changes in 
immune system of pregnant women causing increased 
inflammatory response. According to the second 
theory, increased inflammatory response leads to 
wrong placentation, increased capillary permeability, 
microvascular thrombosis, and increased vascular 
tonus (6,7). 
Mean corpuscular volume (MCV), mean 
corpuscular hemoglobin (MCH), mean corpuscular 
hemoglobin concentration (MCHC), red cell 
distribution width (RDW), and red blood cell (RBC) 
are known as the red blood cell indices. MCV defines 
the size of the red blood cells. MCH determines the 
amount of hemoglobin per red blood cell. MCHC 
indicates the amount of hemoglobin per unit volume 
(8). RDW is an indicator of red cell size variation 
called anisocytosis. It reflects early changes in red 
blood cells. All these parameters are important for 
detecting and investigating anemia (9). They are 
usually evaluated in a fully automated hematology 
analyzer, as part of the complete blood count. In the 
literature, it has been shown that RDW was higher 
in prehypertension. Prehypertension was described 
as slightly elevated blood pressure which would 
likely turn into high blood pressure (hypertension) in 
non-pregnant people if lifestyle changes like eating 
healthier and starting to exercise were not done (10). 
Furthermore, the association between RDW values 
and non-cardiac and cardiac mortality in patients with 
cardiovascular and thrombotic disorders, diabetic 
ketoacidosis, acute and chronic heart failure, coronary 
artery disease, and stroke has been investigated 
(11,12). However in the literature, there have been 
limited data on the relationship between red blood 
cell indices, including RDW, and preeclampsia. In the 
present study, we aimed to investigate the association 
between preeclampsia and red blood cell indices.
Materials and Methods
The present study was approved by the local 
ethics committee of Adnan Menderes University 
Faculty of Medicine, where the study was conducted. 
The study population consisted of 102 patients with 
preeclampsia who were diagnosed between January 
2013-2015 and 98 gestational age-matched control 
participants. The gestational stage of each subject 
was determined by ultrasonography using the fetal 
crown-rump length during the 10th to 12th week of 
gestation. Of the patients with preeclampsia, 49 had 
mild and 53 had severe preeclampsia. Preeclampsia 
was diagnosed based on the practice bulletin on 
the diagnosis and management of preeclampsia 
and eclampsia developed by the American College 
of Obstetricians and Gynecologists in 2002 (13); a 
systolic blood pressure (BP) ≥140 mmHg on more 
than two readings taken 6 hours apart, a diastolic BP 
≥90 mmHg and detectable urinary protein (>1 + by 
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Bulgular: Preeklampsi grubunda, medyan RDW %15 (13,8-16,57), ortalama MCV değeri 80,42±7,86 (fL), ortalama MCHC değeri 
33,66±1,71 (g/dL) ve kontrol grubunda medyan RDW %13,9 (13-15,6), ortalama MCV değeri 83,88±2,31 (fL), ortalama MCHC değeri 
33,09±1,48 (g/dL) idi (sırasıyla p<0,01, p=0,003, p=0,012). Fakat preeklampsi ve kontrol grubunda MCH and RBC değerleri arasında fark 
saptanmadı (p>0,05). Preeklampsi grubunda subgroup analizi yapıldığında, hafif preeklampsi grubuna göre, ciddi preeklampsi grubunda 
artmış RDW değerleri (% 15,4 (13,9-17,45) vs %14,3 (13,7-15,7), p=0,031), azalmış MCV değerleri (78,81±7,91 (fL) vs 82,16±7,43 (fL), 
p=0,03), artmış RBC değerleri (4,16 (3,79-4,85)x(1012/L) vs 3,82 (3,45-4,34)x(1012/L), (p=0,006) saptandı. Preeklampsi ve kontrol grubu 
hastalarının Receiver operatör karakteristik (ROK) analizi sonuçlarına göre eritrosit sayımı ve eritrosit dağılım genişliğinin hastalığı tespit 
etmede yüksek prediktif değerleri saptandı (p<0,01). Ayrıca ROK analiz sonuçlarına göre, hafif ve ciddi preeklampsili hastalarda RDW ve 
RBC değerleri hastalığın ciddiyetini belirlemede ideal prediktif değerlere sahip idi (p=0,006, p=0,031).
Sonuç: Eritrosit indeksleri arasında artmış RDW değerleri hem preeklampsi tanısı, hem de hastalığın ciddiyeti ile ilişkilidir.
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dipstick or 0.3 g/24 hour and more) after 20 weeks of 
gestation. Measured BP should be previously normal. 
Clinical definition of severe preeclampsia (if any) was 
as follows: a BP of ≥160 mmHg/110 mmHg, with 
either a urine dipstick showing 3+ or 4+ in a random 
urine analysis or a proteinuria greater than 5 g over 
24 hours and manifestations of multiple organ damage 
or dysfunction like pulmonary edema, headache, 
oliguria or fetal growth restriction. Mild preeclampsia 
was defined as new onset of blood pressure ≥140/90 
mmHg on more than two readings taken 6 hours apart, 
combined with proteinuria ≥0.3 g/24 hours after 20 
weeks of gestation, but not meeting the standards 
for severe preeclampsia. Patients with chronic 
hypertension, infectious diseases diagnosed during 
pregnancy, polyhydramnios, active labor, premature 
rupture of membrane, anemia, inflammatory diseases, 
and kidney diseases were excluded from the study. 
Control group included all healthy women with a 
singleton gestation and a normal obstetric history. The 
control group had blood pressures less than 140/90 
mmHg, or no proteinuria. They also had no sign of any 
gestational complication or fetal distress. Pregnant 
women in the control group all delivered congenitally 
healthy, full-term live births. Written informed consent 
was received from all participant and their families.
All participants underwent blood collection before 
birth via antecubital vein puncture. The red blood 
cell indices were measured as part of the automated 
complete blood count using a Mindray BC 6800 
analyzer (M68 LH LYSE, Shenzhen, China).
The Kolmogorov-Smirnov test was used to 
assess the normality of numeric variables. For the 
numeric variables that were normally distributed, 
comparison between the two groups was made by 
independent sample t-test and descriptive statistics 
are presented as mean ± standard deviation. For the 
numeric variables that were not normally distributed, 
comparison between the two groups was made by the 
Mann-Whitney U test and descriptive statistics are 
presented as median (25-75 percentiles). To analyze 
the categorical data, a chi-square test was used and 
descriptive statistics are presented as frequency 
(%). Spearman’s correlation coefficient was used for 
qualitative data and Pearson’s correlation coefficient 
for quantitative data. Receiver operator characteristic 
(ROC) curve analysis and calculation of the area under 
the curve (AUC) were performed. Statistical analysis 
was performed using the Statistical Package for 
Social Sciences (SPSS Inc., Chicago, IL, USA) statistical 
software for Windows (Version 18.0). A p value of less 
than 0.05 was regarded as statistically significant.
Results
A total of 200 patients (mean age: 29.77±5.62 
ranged from 18 to 43) were included in the study. In 
the preeclampsia group, the median RDW was 15% 
(13.8-16.57), whereas in the control group it was 
13.9% (13-15.6) (p<0.01). On the other hand, the 
mean MCV value was 80.42±7.86 (fL) in preeclampsia 
group and 83.88±2.31 (fL) in control group (p=0.003). 
Besides, the mean MCHC value was 33.66±1.71 (g/
dL) in preeclampsia group and 33.09±1.48 (g/dL) 
in control group (p=0.012). However, MCH and RBC 
values were not statistically different between the 
groups (p>0.05). The baseline characteristics of the 
patients with preeclampsia and without preeclampsia 
are summarized in Table 1.
Of the women with preeclampsia, 53 patients 
(52%) had severe preeclampsia. In addition, subgroup 
analysis revealed that the RDW levels were higher in 
patients with severe preeclampsia (p=0.031) (Figure 
1). On the other hand, the mean MCV value was 
78.81±7.91 (fL) in severe preeclampsia group and 
82.16±7.43 (fL) in mild preeclampsia group (p=0.03). 
In severe preeclampsia group, RBC was 4.16 (3.79-
4.85)x(1012/L) and it was 3.82 (3.45-4.34)x(1012/L) 
in mild preeclampsia group (p=0.006). However, 
MCHC and MCH values were not statistically different 
between the groups (p>0.05) (Table 2).
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Figure 1. Comparison of red cell distribution width levels in 
the mild preeclampsia, severe preeclampsia and controls
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Analysis of ROC curves for blood parameters and 
red blood cell indices for predicting the onset of 
preeclampsia and the severity of preeclampsia
The ROC analysis of AST, ALT, Crea, Alb, Hgb, Hct, 
WBC, PLT, MCV, MCHC, RBC, and RDW was performed 
in all subjects of all groups. Of these parameters; AST, 
Crea, Alb, also MCV, MCHC and RDW were considered 
to be possible predictors of preeclampsia (p<0.01, 
p=0.032, p<0.01, p<0.01, p=0.005 and p<0.01, 
respectively) (Table 3) (Figure 2).
The ROC analysis of AST, ALT, Crea, Alb, Hgb, Hct, 
WBC, PLT, MCV, MCHC, RBC, and RDW was performed 
in subjects in only preeclampsia group. Of these 
parameters; AST, Alb and also RBC and RDW were 
considered to be possible predictors of severity 
of preeclampsia (p=0.004, p=0.001, p=0.006 and 
p=0.031, respectively) (Table 4) (Figure 3).
Discussion
In present study, RDW was found to be higher 
in preeclampsia and severe preeclampsia group 
compared to controls. In addition, our study results 
revealed that among the red blood cell indices, only 
RDW levels were associated with both the presence 
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Table 1. Baseline characteristics of pregnant women with preeclampsia and patients in control group
Variables Controls (n=98) 




Age (years) 28.55±4.91 30.94±6.02 0.020
Gestational age (weeks) 37.04±1.42 37.03±0.94 >0.05
Nulliparity (%) 25 (25.5%) 41 (40.2%) 0.027
C-S1 (%) 53 (54.1%) 85 (83.3%) <0.01
Birth weight (gr) 3191.58±522.05 2537.54±939.69 <0.01
AST3 17 (14-18) 18.5 (15-26.25) <0.01
ALT4 13 (11-15) 13 (10-20) >0.05
Crea5 0.6 (0.6-0.7) 0.63 (0.60-0.70) 0.028
Alb6 3.81±0.56 3.26±0.57 <0.01
Hgb7 (g/dl) 11.15±1.29 10.95±1.91 >0.05
Hct8 (%) 34 (31.27-36.2) 34.2 (31.07-37.85) >0.05
PLT9 (×109/L) 217.97±73.61 223.77±85.80 >0.05
WBC10 (×109/L) 10500 (8945-12175) 10500 (9145-12725) >0.05
RDW11 (%) 13.9 (13-15.6) 15 (13.8-16.57) <0.01
MCV12 (fL) 83.88±2.31 80.42±7.86 0.003
MCHC13 (g/dL) 33.09±1.48 33.66±1.71 0.012
MCH14 (pg) 28.6 (24.9-30.4) 28.15 (25.5-30.82) >0.05
RBC15 (1012/L) 3.94 (3.69-4.34) 3.94 (3.63-4.64) >0.05
C-S1: Cesarean section, NVB2: Normal vaginal birth, AST3: Aspartate aminotransferase, ALT4: Alanin Aminotransferase, Crea5: Creatinin, Alb6: Albumin, 
Hgb7: Hemoglobin, Hct8: Hematocrit, Plt9: Platelet, WBC10: White blood cell, RDW11: Red cell distribution width , MCV12: Mean corpuscular volume, 
MCHC13: Mean corpuscular hemoglobin concentration, MCH14: Mean corpuscular hemoglobin, RBC15: Red blood cell
Figure 2. Receiver operator characteristic curves for 
aspartate aminotransferase, creatinin, albumin, red cell 
distribution width, mean corpuscular volume, mean 
corpuscular hemoglobin concentration for predicting 
preeclampsia
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and the severity of preeclampsia. In the literature, there 
have been one study from Sudan (14) and one study 
from Turkey (15) that investigated the relationship of 
RDW width with preeclampsia. The study from Sudan 
including 65 patients in study and 65 in control groups 
found that RDW levels were not associated with the 
presence or severity of preeclampsia (14), but the 
study from Turkey determined higher levels of RDW 
in patients with preeclampsia (15). 
RDW is routinely examined with the complete 
blood count test that showing the heterogeneity in 
erythrocyte size. Recent studies have reported the 
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Table 2. Baseline characteristics of pregnant women with mild and severe preeclampsia
Variables Mild preeclampsia (n=49) 
(Mean ± SD/Median)
Severe preeclampsia (n=53) 
(Mean ± SD/Median)
p
Age (years) 31.81±5.56 30.13±6.36 >0.05
Gestational age (weeks) 37.04±2.38 33.32±4.37 <0.01
Nulliparity (%) 18 (36.7%) 23 (43.4%) >0.05
C-S1 (%) 35 (71.4%) 50 (94.3%) 0.002
Birth weight (gr) 3124.79±678.89 2034.90±846.34 <0.01
AST3 17 (14.5-20.5) 19 (16-36) 0.004
ALT4 13 (9-19) 13 (11-22) >0.05
Crea5 0.62 (0.6-0.7) 0.65 (0.6-0.75) >0.05
Alb6 3.45±0.55 3.08±0.53 0.001
Hgb7 (g/dl) 11.20±1.89 10.71±1.91 >0.05
Hct8 (%) 34 (30.4-37.1) 34.8 (31.4-38.5) >0.05
PLT9 (×109/L) 227.81±63.14 220.03±102.91 >0.05
WBC10 (×109/L) 10500 (8645-12400) 10500 (9375-13905) >0.05
RDW11 (%) 14.3 (13.7-15.7) 15.4 (13.9-17.45) 0.031
MCV12 (fL) 82.16±7.43 78.81±7.91 0.03
MCHC13 (g/dL) 33.94±1.32 33.41±1.98 >0.05
MCH14 (pg) 28.10 (25.7-31) 28.3 (24.75-30.6) >0.05
RBC15 (1012/L) 3.82 (3.45-4.34) 4.16 (3.79-4.85) 0.006
C-S1: Cesarean section, NVB2: Normal vaginal birth, AST3: Aspartate aminotransferase, ALT4: Alanin aminotransferase, Crea5: Creatinin, Alb6: Albumin, 
Hgb7: Hemoglobin, Hct8: Hematocrit, Plt9: Platelet, WBC10: White blood cell, RDW11: Red cell distribution width, MCV12: Mean corpuscular volume, 
MCHC13: Mean corpuscular hemoglobin concentration, MCH14: Mean corpuscular hemoglobin, RBC15: Red blood cell 
Table 3. Receiver operator characteristic analysis for aspartate aminotransferase, creatinin, albumin, red cell 
distribution width, mean corpuscular volume, mean corpuscular hemoglobin concentration for predicting preeclampsia
Area Under Curve
Test result variable Area Cut off value Sensitivity-specificity (%) Standard error p value 95% Cls
Lower bound Upper bound
AST1 (U/L) 0.643 >18 50-78.57% 0.039 <0.01 0.567 0.720
Crea2 (mg/dl) 0.588 >0.6 59.80-67.35% 0.041 0.032 0.508 0.667
Alb3 (g/dL) 0.753 ≤0.36 72.55-66.33% 0.034 <0.01 0.687 0.819
MCV4 (fL) 0.654 ≤84.4 74.51-56.12% 0.039 <0.01 0.577 0.731
MCHC5 (g/dL) 0.615 >34.3 35.29-82.65% 0.039 <0.01 0.537 0.692
RDW6 (%) 0.645 >13.6 81.37-43.88% 0.039 <0.01 0.569 0.722
AST1: Aspartate aminotransferase, Crea2: Creatinin, Alb3: Albumin, MCV4: Mean corpuscular volume, MCHC5: Mean corpuscular hemoglobin 
concentration, RDW6: Red cell distribution width 
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association between high RDW levels and increased 
mortality (16) in patients with cardiovascular disease 
(17), brain vascular disease (18), septicemia (19), 
chronic obstructive pulmonary disease (20), and 
hepatitis B (21). Besides, the activity of inflammatory 
bowel disease (22) as well as pulmonary functions (23) 
has also been reported to be associated with RDW 
values (24). RDW has been recently determined to be 
associated with hypertension and it was an indicator 
of poor prognosis in heart failure and acute myocardial 
infarction (10,25,26). Although the mechanism of the 
relationship between hypertension and RDW was not 
clearly understood, increased inflammation was the 
most reasonable theory (27).
In the literature, there is only limited data on the 
influence of normal pregnancy on RDW. Between 
16 and 34 weeks of gestation, it is stable (27), but 
between 34 weeks of gestation and the onset of 
labor, high RDW values have been reported (28). 
Similar to the relationship of inflammation with 
increased RDW values in hypertensive non-pregnant 
women, inflammatory theory has been also blamed 
for increased RDW values preeclamptic women. In a 
study by Kurt et al. (15), a positive correlation between 
high-sensitivity C-reactive protein and increased RDW 
levels was determined in preeclamptic women. 
In preeclamptic women, another issue supporting 
inflammatory theory was increased levels of lactoferrin 
due to neutrophil activation (29). Besides, in a study 
performed in rats, proteinuria and preeclampsia 
developed after giving endotoxin after 14th day of 
pregnancy (30). That condition has also shown that 
any inflammatory reaction during implantation 
and placentation might cause preeclampsia during 
pregnancy (5). Therefore, placental hypoxia due 
to inflammation leads to increased stimulation of 
erythropoiesis (31). Immature erythrocytes enter 
the circulation (32). As these erythrocytes have 
poor repair mechanisms, they may be destroyed by 
any minor event causing damage. In preeclampsia, 
increased inflammatory process also causes the 
destruction of red blood cells by reaction with 
oxygen radicals and proteolytic enzymes. After this 
destruction, the levels of some catabolic products, 
such as erythrocyte membrane band 3 protein, 
increase (33-35). Besides, tissue hypoxia-induced 
erythropoietin secretion stimulates bone marrow 
(36). In the literature, increased erythropoietin 
also was determined in patients with preeclampsia 
(37). Increased erythropoietin levels supported that 
inflammation induced hypoxia in in preeclampsia. So 
inflammatory theory, placental hypoxia, red blood cell 
destruction and defective erythropoisesis might help 
us explain the high RDW values indicating different size 
of erythrocytes in preeclampsia. Especially increased 
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Table 4. Receiver operator characteristic curves for aspartate aminotransferase, albumin, red blood cell, red cell 
distribution width for predicting severity of preeclampsia
Area Under Curve
Test result variable Area Cut off value Sensitivity-specificity (%) Standard error p value 95% Cls
Lower bound Upper bound
AST1 (U/L) 0.665 >25 39.62-87.76% 0.053 0.004 0.561 0.769
Alb2 (g/dL) 0.689 ≤3.6 86.79-42.86% 0.053 0.001 0.586 0.792
RBC3 (1012/L) 0.659 >4.23 49.06-75.51% 0.054 0.006 0.553 0.765
RDW4 (%) 0.624 >15.2 56.60-71.42% 0.056 0.031 0.514 0.734
AST1: Aspartate aminotransferase, Alb2: Albumin, RBC3: Red blood cell, RDW4: Red cell distribution width 
Figure 3. Receiver operator characteristic curves for 
aspartate aminotransferase, albumin, red blood cell, red cell 
distribution width for predicting severity of preeclampsia
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RDW values have predictive value for diagnosing 
preeclampsia including severe and mild types.
Another red blood cell index is MCV. In pregnancy, 
MCV value has been found to increase about 3-5 (fL) 
(38). In the present study, MCV was determined to 
be lower in preeclampsia and severe preeclampsia 
groups in contrast to the literature (39). In another 
study, it was found that there was no difference 
in MCV values between preeclamptic women and 
controls (40). In the present study, in addition to 
decreased values of MCV, unchanged MCH and RBC 
values in patients with preeclampsia might be due to 
unsatisfactory iron replacement therapy. In addition, 
the study population was living in the western part of 
Turkey in which vegetable nutrition is common. As we 
know, nutritional status (e.g. iron, folate, and vitamin 
B12 deficiency) and eating habits (41,42) may affect 
red blood cell indices. Thus, one limitation of our 
study is not to investigate iron, folate and vitamin B12 
levels in the participants due to financial constraints.
Consistent with the literature, no significant 
difference was found in Hgb, Hct, WBC, PLT, RBC, and 
MCH levels between patients with preeclampsia and 
controls (37,40). In contrast to the literature, we did 
not observe any increase in Hct and any decrease in 
PLT, especially in severe form of preeclampsia, despite 
we expected to see (14,43). Conflicting results may 
be mainly due to the small number of subjects in 
severe and mild preeclampsia groups. We have also 
determined that AST, ALT, and creatinin levels were 
higher and albumin levels were lower in patients with 
preeclampsia, and especially, AST levels were higher, 
albumin levels were lower in severe preeclampsia 
group. It may be explained by damage to the renal 
and hepatic systems confirmed by a significant 
increase in blood markers (40). In the present study, 
especially lower albumin levels had predictive values 
for preeclampsia and severe preeclampsia together 
with increased RDW levels.
In conclusion, complete blood count test, 
including especially RDW, is an easy, inexpensive, 
routinely reported investigation, which might 
allow the acquisition of significant diagnostic and 
prognostic information in patients with preeclampsia 
and to determine the severity of preeclampsia. 
However, results of our study should be confirmed 
by multicentre studies including larger number of 
cases in addition to controlling nutritional status of 
participants by measuring iron, folate and vitamin B12 
levels.
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